Approval was based on data from the Phase IIb SunRISe-1 trial (NCT04640623), in which Inlexzo demonstrated an 82% complete ...

Actress Danielle Fishel shared her breast cancer diagnosis this week, revealing on Monday’s episode of her podcast, “Pod Meets World,” that she is being treated for ductal carcinoma in situ. “It is ...

TAR-200 eliminated tumors in 82% of patients in a phase 2 trial for patients with high-risk non-muscle-invasive bladder ...

The FDA has approved Inlexzo for adults with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ.

The FDA has approved Inlexzo (gemcitabine intravesical system) for the treatment of adult patients with BCG-unresponsive, non-muscle invasive bladder cancer with CIS with or without papillary tumors.

Please provide your email address to receive an email when new articles are posted on . A significant number of women with non-screen-detected ductal carcinoma in situ had invasive cancer or breast ...

DCIS is a type of breast cancer that occurs when abnormal cells appear in the breast’s milk ducts. “In situ” means “in place,” so the cancer has not spread beyond the milk ducts. What are some ...

The indication for the chemotherapy-containing system stipulates use in adults with bacillus Calmette-Guerin ...

Stage 0 cancer, or carcinoma in situ, is the earliest form of cancer where abnormal cells remain localized. Experts stress ...

Danielle Fishel joined "Dancing with the Stars" after completing breast cancer treatment, seeking more joy and fun in her ...